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Abstract
In this work, we present a fully automated lung computed
tomography (CT) cancer diagnosis system, DeepLung.
DeepLung consists of two components, nodule detection
(identifying the locations of candidate nodules) and clas-
sification (classifying candidate nodules into benign or ma-
lignant). Considering the 3D nature of lung CT data and
the compactness of dual path networks (DPN), two deep
3D DPN are designed for nodule detection and classifica-
tion respectively. Specifically, a 3D Faster Regions with
Convolutional Neural Net (R-CNN) is designed for nod-
ule detection with 3D dual path blocks and a U-net-like
encoder-decoder structure to effectively learn nodule fea-
tures. For nodule classification, gradient boosting machine
(GBM) with 3D dual path network features is proposed.
The nodule classification subnetwork was validated on a
public dataset from LIDC-IDRI, on which it achieved bet-
ter performance than state-of-the-art approaches and sur-
passed the performance of experienced doctors based on
image modality. Within the DeepLung system, candidate
nodules are detected first by the nodule detection subnet-
work, and nodule diagnosis is conducted by the classifi-
cation subnetwork. Extensive experimental results demon-
strate that DeepLung has performance comparable to expe-
rienced doctors both for the nodule-level and patient-level
diagnosis on the LIDC-IDRI dataset.1
1. Introduction
Lung cancer is the most common cause of cancer-related
death in men. Low-dose lung CT screening provides an ef-
fective way for early diagnosis, which can sharply reduce
the lung cancer mortality rate. Advanced computer-aided
diagnosis systems (CADs) are expected to have high sensi-
tivities while at the same time maintaining low false positive
rates. Recent advances in deep learning enable us to rethink
the ways of clinician lung cancer diagnosis.
1https://github.com/uci-cbcl/DeepLung.git
Current lung CT analysis research mainly includes nod-
ule detection [6, 5], and nodule classification [26, 25, 14,
33]. There is few work on building a complete lung CT
cancer diagnosis system for fully automated lung CT can-
cer diagnosis using deep learning, integrating both nodule
detection and nodule classification. It is worth exploring a
whole lung CT cancer diagnosis system and understanding
how far the performance of current deep learning technol-
ogy differs from that of experienced doctors. To our best
knowledge, this is the first work for a fully automated and
complete lung CT cancer diagnosis system using deep nets.
The emergence of large-scale dataset, LUNA16 [24],
accelerated the nodule detection related research. Typi-
cally, nodule detection consists of two stages, region pro-
posal generation and false positive reduction. Traditional
approaches generally require manually designed features
such as morphological features, voxel clustering and pixel
thresholding [20, 15]. Recently, deep ConvNets, such as
Faster R-CNN [21, 17] and fully ConvNets [18, 37, 31, 30,
29], are employed to generate candidate bounding boxes
[5, 6]. In the second stage, more advanced methods or com-
plex features, such as carefully designed texture features,
are used to remove false positive nodules. Because of the
3D nature of CT data and the effectiveness of Faster R-CNN
for object detection in 2D natural images [13], we design a
3D Faster R-CNN for nodule detection with 3D convolu-
tional kernels and a U-net-like encoder-decoder structure to
effectively learn latent features [22]. The U-Net structure is
basically a convolutional autoencoder, augmented with skip
connections between encoder and decoder layers [22]. Al-
though it has been widely used in the context of semantic
segmentation, being able to capture both contextual and lo-
cal information should be very helpful for nodule detections
as well. Because 3D ConvNet has too large a number of pa-
rameters and is difficult to train on public lung CT datasets
of relatively small sizes, 3D dual path network is employed
as the building block since deep dual path network is more
compact and provides better performance than deep resid-
ual network at the same time [3].
Before the era of deep learning, manual feature engi-
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Figure 1. The framework of DeepLung. DeepLung first employs 3D Faster R-CNN to generate candidate nodules. Then it uses deep 3D
DPN to extract deep features from the detected and cropped nodules. Lastly, GBM with deep features, detected nodule size, and raw pixels
is employed for classification. Patient-level diagnosis can be achieved by fusing the classification results of detected nodules in the CT.
neering followed by classifiers was the general pipeline for
nodule classification [10]. After the large-scale LIDC-IDRI
[2] dataset became publicly available, deep learning-based
methods have become the dominant framework for nod-
ule classification research [25, 35]. Multi-scale deep Con-
vNet with shared weights on different scales has been pro-
posed for the nodule classification [26]. The weight sharing
scheme reduces the number of parameters and forces the
multi-scale deep ConvNet to learn scale-invariant features.
Inspired by the recent success of dual path network (DPN)
on ImageNet [3, 4], we propose a novel framework for CT
nodule classification. First, we design a deep 3D dual path
network to extract features. As gradient boosting machines
(GBM) are known to have superb performance given effec-
tive features, we use GBM with deep 3D dual path features,
nodule size, and cropped raw nodule CT pixels for the nod-
ule classification [8].
Finally, we built a fully automated lung CT cancer di-
agnosis system, henceforth called DeepLung, by combin-
ing the nodule detection network and nodule classification
network together, as illustrated in Fig. 1. For a CT im-
age, we first use the detection subnetwork to detect candi-
date nodules. Next, we employ the classification subnet-
work to classify the detected nodules into either malignant
or benign. Finally, the patient-level diagnosis result can be
achieved for the whole CT by fusing the diagnosis result of
each nodule.
Our main contributions are as follows: 1) To fully ex-
ploit the 3D CT images, two deep 3D ConvNets are de-
signed for nodule detection and classification respectively.
Because 3D ConvNet contains too many parameters and is
difficult to train on relatively small public lung CT datasets,
we employ 3D dual path networks as the neural network
architecture since DPN uses less parameters and obtains
better performance than residual network [3]. Specifically,
inspired by the effectiveness of Faster R-CNN for object
detection [13], we propose 3D Faster R-CNN for nodule
detection based on 3D dual path network and U-net-like
encoder-decoder structure, and deep 3D dual path network
for nodule classification. 2) Our classification framework
achieves better performance compared with state-of-the-art
approaches, and surpasses the performance of experienced
doctors on the public dataset, LIDC-IDRI. 3) Our fully au-
tomated DeepLung system, nodule classification based on
detection, is comparable to the performance of experienced
doctors both on nodule-level and patient-level diagnosis.
2. Related Work
Traditional nodule detection involves hand-designed fea-
tures or descriptors [19] requiring domain expertise. Re-
cently, several works have been proposed to use deep Con-
vNets for nodule detection to automatically learn features,
which is proven to be much more effective than hand-
designed features. Setio et al. proposes multi-view Con-
vNet for false positive nodule reduction [23]. Due to the
3D nature of CT scans, some work proposed 3D ConvNets
to handle the challenge. The 3D fully ConvNet (FCN) is
proposed to generate region candidates, and deep ConvNet
with weighted sampling is used for false positive reduction
[6]. Ding et al. and Liao et al. use the Faster R-CNN to
generate candidate nodules followed by 3D ConvNets to re-
move false positive nodules [5, 17]. Due to the effective
performance of Faster R-CNN [13, 21], we design a novel
network, 3D Faster R-CNN with 3D dual path blocks, for
the nodule detection. Further, a U-net-like encoder-decoder
scheme is employed for 3D Faster R-CNN to effectively
learn the features [22].
Nodule classification has traditionally been based on
segmentation [7] and manual feature design [1]. Several
works designed 3D contour feature, shape feature and tex-
ture feature for CT nodule diagnosis [32, 7, 10]. Recently,
deep networks have been shown to be effective for medical
images. Artificial neural network was implemented for CT
nodule diagnosis [28]. More computationally effective net-
work, multi-scale ConvNet with shared weights for differ-
ent scales to learn scale-invariant features, is proposed for
Figure 2. Illustration of dual path connection [3], which benefits
both from the advantage of residual learning [11] and that of dense
connection [12] from network structure design intrinsically.
nodule classification [26]. Deep transfer learning and multi-
instance learning is used for patient-level lung CT diagno-
sis [25, 36]. A comparative study on 2D and 3D ConvNets
is conducted and 3D ConvNet is shown to be better than
2D ConvNet for 3D CT data [33]. Furthermore, a multi-
task learning and transfer learning framework is proposed
for nodule diagnosis [14]. Different from their approaches,
we propose a novel classification framework for CT nod-
ule diagnosis. Inspired by the recent success of deep dual
path network (DPN) on ImageNet [3], we design a novel
3D DPN to extract features from raw CT nodules. In part to
the superior performance of GBM with complete features,
we employ GBM with different levels of granularity rang-
ing from raw pixels, DPN features, to global features such
as nodule size for the nodule diagnosis. Patient-level diag-
nosis can be achieved by fusing the nodule-level diagnosis.
3. DeepLung Framework
Our fully automated lung CT cancer diagnosis system
consists of two parts: nodule detection and classification.
We design a 3D Faster R-CNN for nodule detection, and
propose GBM with deep 3D DPN features, raw nodule CT
pixels and nodule size for nodule classification.
3.1. 3D Faster R-CNN with Deep 3D Dual Path Net
for Nodule Detection
Inspired by the success of dual path network on the Ima-
geNet [3, 4], we design a deep 3D DPN framework for lung
CT nodule detection and classification in Fig. 3 and Fig.
4. Dual path connection benefits both from the advantage
of residual learning and that of dense connection [11, 12].
The shortcut connection in residual learning is an effective
way to eliminate vanishing gradient phenomenon in very
deep networks. From a learned feature sharing perspective,
residual learning enables feature reuse, while dense connec-
tion has an advantage of exploiting new features [3]. Addi-
tionally, densely connected network has fewer parameters
than residual learning because there is no need to relearn
redundant feature maps. The assumption of dual path con-
nection is that there might exist some redundancy in the ex-
ploited features. And dual path connection uses part of fea-
ture maps for dense connection and part of them for resid-
ual learning. In implementation, the dual path connection
splits its feature maps into two parts. One part, F(x)[d :],
is used for residual learning, the other part, F(x)[: d], is
used for dense connection as shown in Fig. 2. Here d is a
hyper-parameter for deciding how many new features to be
exploited. The dual path connection can be formulated as
y = G([x[: d],F(x)[: d],F(x)[d :] + x[d :]), (1)
where y is the feature map for dual path connection, G is
used as ReLU activation function, F is convolutional layer
functions, and x is the input of dual path connection block.
Dual path connection integrates the advantages of the two
advanced frameworks, residual learning for feature reuse
and dense connection for the ability to exploit new features,
into a unified structure which obtained success on the Ima-
geNet dataset[4]. We design deep 3D neural nets based on
3D DPN because of its compactness and effectiveness.
The 3D Faster R-CNN with a U-net-like encoder-
decoder structure and 3D dual path blocks is illustrated in
Fig. 3. Due to the GPU memory limitation, the input of 3D
Faster R-CNN is cropped from 3D reconstructed CT im-
ages with pixel size 96 × 96 × 96. The encoder network
is derived from 2D DPN [3]. Before the first max-pooling,
two convolutional layers are used to generate features. Af-
ter that, eight dual path blocks are employed in the encoder
subnetwork. We integrate the U-net-like encoder-decoder
design concept in the detection to learn the deep nets effi-
ciently [22]. In fact, for the region proposal generation, the
3D Faster R-CNN conducts pixel-wise multi-scale learning
and the U-net is validated as an effective way for pixel-wise
labeling. This integration makes candidate nodule gener-
ation more effective. In the decoder network, the feature
maps are processed by deconvolution layers and dual path
blocks, and are subsequently concatenated with the corre-
sponding layers in the encoder network [34]. Then a convo-
lutional layer with dropout (dropout probability 0.5) is used
in the second to the last layer. In the last layer, we design 3
anchors, 5, 10, 20, for scale references which are designed
based on the distribution of nodule sizes. For each anchor,
there are 5 parts in the loss function, classification loss Lcls
for whether the current box is a nodule or not, regression
loss Lreg for nodule coordinates x, y, z and nodule size d.
If an anchor overlaps a ground truth bounding box with
the intersection over union (IoU) higher than 0.5, we con-
sider it as a positive anchor (p? = 1). On the other hand,
if an anchor has IoU with all ground truth boxes less than
0.02, we consider it as a negative anchor (p? = 0). The
multi-task loss function for the anchor i is defined as
L(pi, ti) = λLcls(pi, p
?
i ) + p
?
iLreg(ti, ti
?), (2)
Figure 3. The 3D Faster R-CNN framework contains 3D dual path
blocks and a U-net-like encoder-decoder structure. We design 26
layers 3D dual path network for the encoder subnetwork. The
model employs 3 anchors and multi-task learning loss, including
coordinates (x, y, z) and diameter d regression, and candidate box
classification. The numbers in boxes are feature map sizes in the
format (#slices*#rows*#cols*#maps). The numbers above the
connections are in the format (#filters #slices*#rows*#cols).
Figure 4. The deep 3D dual path network framework in the nodule
classification subnetwork, which contains 30 3D dual path con-
nection blocks. After the training, the deep 3D dual path network
feature is extracted for gradient boosting machine to do nodule
diagnosis. The numbers are of the same formats as Fig. 3.
where pi is the predicted probability for current anchor i
being a nodule, ti is the predicted relative coordinates for
nodule position, which is defined as
ti = (
x− xa
da
,
y − ya
da
,
z − za
da
, log(
d
da
)), (3)
where (x, y, z, d) are the predicted nodule coordinates and
diameter in the original space, (xa, ya, za, da) are the coor-
dinates and scale for the anchor i. For ground truth nodule
position, it is defined as
t?i = (
x? − xa
da
,
y? − ya
da
,
z? − za
da
, log(
d?
da
)), (4)
where (x?, y?, z?, d?) are nodule ground truth coordinates
and diameter. The λ is set as 0.5. For Lcls, we used binary
cross entropy loss function. For Lreg , we used smooth l1
regression loss function [9].
3.2. Gradient Boosting Machine with 3D Dual Path
Net Feature for Nodule Classification
For CT data, advanced method should be effective to ex-
tract 3D volume feature [33]. We design a 3D deep dual
path network for the 3D CT lung nodule classification in
Fig. 4. The main reason we employ dual modules for de-
tection and classification is that classifying nodules into be-
nign and malignant requires the system to learn finer-level
features, which can be achieved by focusing only on nod-
ules. In addition, it allows to introduce extra features in the
final classification. We first crop CT data centered at pre-
dicted nodule locations with size 32 × 32 × 32. After that,
a convolutional layer is used to extract features. Then 30
3D dual path blocks are employed to learn higher level fea-
tures. Lastly, the 3D average pooling and binary logistic
regression layer are used for benign or malignant diagnosis.
The deep 3D dual path network can be used as a clas-
sifier for nodule diagnosis directly and it can also be em-
ployed to learn effective features. We construct feature by
concatenating the learned deep 3D DPN features (the sec-
ond from the last layer (2,560 dimension)), nodule size, and
raw 3D cropped nodule pixels. Given complete and effec-
tive features, GBM is a superb method to build an advanced
classifier [8]. We validate the feature combining nodule size
with raw 3D cropped nodule pixels in combination with the
GBM classifier and obtained 86.12% average test accuracy.
Lastly, we employ GBM with the constructed feature and
achieve the best diagnosis performance.
3.3. DeepLung System: Fully Automated Lung CT
Cancer Diagnosis
The DeepLung system includes the nodule detection us-
ing the 3D Faster R-CNN and nodule classification using
GBM with constructed feature (deep 3D dual path features,
nodule size and raw nodule CT pixels) as shown in Fig. 1.
Due to the GPU memory limitation, we first split the
whole CT into several 96 × 96 × 96 patches, process them
through the detector, and combine the detected results to-
gether. We only keep the detected boxes of detection prob-
abilities larger than 0.12 (threshold as -2 before sigmoid
function). After that, non-maximum suppression (NMS) is
adopted based on detection probability with the intersection
over union (IoU) threshold as 0.1. Here we expect to not
miss too many ground truth nodules.
After we get the detected nodules, we crop the nodule
with the center as the detected center and size of 32× 32×
32. The detected nodule size is kept as a feature input for
later downstream classification. The deep 3D DPN is em-
ployed to extract features. We use the GBM and construct
features to conduct diagnosis for the detected nodules. For
pixel feature, we use the cropped size of 16 × 16 × 16
and center as the detected nodule center in the experiments.
For patient-level diagnosis, if one of the detected nodules is
positive (cancer), the patient is classified as having cancer.
Conversely, if all detected nodules are negative, the patient
is considered non-cancer.
4. Experiments
We conduct extensive experiments to validate the
DeepLung system. We perform 10-fold cross validation us-
ing the detector on LUNA16 dataset. For nodule classifi-
cation, we use the LIDC-IDRI annotation, and employ the
LUNA16’s patient-level dataset split. Finally, we also val-
idate the whole system based on the detected nodules both
on patient-level diagnosis and nodule-level diagnosis.
In the training, for each model, we use 150 epochs in
total with stochastic gradient descent optimization and mo-
mentum as 0.9. The batch size parameter is limited by GPU
memory. We use weight decay as 1 × 10−4. The initial
learning rate is 0.01, 0.001 after half the total number of
epoch, and 0.0001 after epoch 120.
4.1. Datasets
LUNA16 dataset is a subset of the largest publicly avail-
able dataset for pulmonary nodules, LIDC-IDRI [2, 24].
LUNA16 dataset only has the detection annotations, while
LIDC-IDRI contains almost all the related information for
low-dose lung CTs including several doctors’ annotations
on nodule sizes, locations, diagnosis results, nodule texture,
nodule margin and other informations. LUNA16 dataset
removes CTs with slice thickness greater than 3mm, slice
spacing inconsistent or missing slices from LIDC-IDRI
dataset, and explicitly gives the patient-level 10-fold cross
validation split of the dataset. LUNA16 dataset contains
888 low-dose lung CTs, and LIDC-IDRI contains 1,018
low-dose lung CTs. Note that LUNA16 dataset removes
the annotated nodules of size smaller than 3mm.
For nodule classification, we extract nodule annotations
from LIDC-IDRI dataset, find the mapping of different doc-
tors’ nodule annotations with the LUNA16’s nodule annota-
tions, and obtained the ground truth of nodule diagnosis by
averaging different doctors’ diagnosis (discarding 0 score
for diagnosis which corresponds to N/A.). If the final av-
erage score is equal to 3 (uncertain about malignant or be-
nign), we remove the nodule. For the nodules with score
greater than 3, we label them as positive. Otherwise, we
label them as negative. Because CT slides were annotated
by anonymous doctors, the identities of doctors (referred to
as Drs 1-4 as the 1st-4th annotations) are not strictly con-
sistent. As such, we refer them as “simulated” doctors. To
make our results reproducible, we only keep the CTs within
LUNA16 dataset, and use the same cross validation split as
LUNA16 for classification.
4.2. Preprocessing
Three automated preprocessing steps are employed for
the input CT images. First, we clip the raw data into
[−1200, 600]. Second, we transform the range linearly
into [0, 1]. Finally, we use LUNA16’s given segmentation
ground truth and remove the background.
Figure 5. The 3D Faster R-CNN network with 3D residual blocks.
It contains several 3D residual blocks. We employ a deep 3D resid-
ual network of 18 layers as the encoder subnetwork, which is an
extension from 2D Res18 net [11].
4.3. DeepLung for Nodule Detection
We train and evaluate the detector on LUNA16 dataset
following 10-fold cross validation with given patient-level
split. In training, we augment the dataset by randomly flip-
ping the image and use cropping scale betweeb 0.75 to 1.25.
The evaluation metric, FROC, is the average recall rate at
the average number of false positives at 0.125, 0.25, 0.5,
1, 2, 4, 8 per scan, which is the official evaluation metric
for LUNA16 dataset [24]. In the test phase, we use detec-
tion probability threshold as -2 (before sigmoid function),
followed by NMS with IoU threshold as 0.1.
To validate the performance of proposed deep 3D dual
path network for detection, we employ a deep 3D residual
network as a comparison in Fig. 5. The encoder part of
this baseline network is a deep 3D residual network of 18
layers, which is an extension from 2D Res18 net [11]. Note
that the 3D Res18 Faster R-CNN contains 5.4M trainable
parameters, while the 3D DPN26 Faster R-CNN employs
1.4M trainable parameters, which is only 14 of 3D Res18
Faster R-CNN.
The FROC performance on LUNA16 is visualized in
Fig. 6. The solid line is interpolated FROC based on true
prediction. The 3D DPN26 Faster R-CNN achieves a FROC
score of 84.2% without any false positive nodule reduc-
tion stage, which is better than the previous 83.9% using
two-stage training [6]. The 3D DPN26 Faster R-CNN us-
ing only 14 of the parameters performs better than the 3D
Res18 Faster R-CNN, which demonstrates the superior suit-
ability of the 3D DPN for detection. Ding et al. obtains
89.1% FROC using 2D Faster R-CNN followed by extra
false positive reduction classifier [5], while we only employ
enhanced Faster R-CNN with deep 3D dual path for detec-
tion. We have recently applied the 3D model to Alibaba
Tianchi Medical AI on nodule detection challenge and were
able to achieve top accuracy on a hold-out dataset.
4.4. DeepLung for Nodule Classification
We validate the nodule classification performance of
the DeepLung system on the LIDC-IDRI dataset with the
LUNA16’s split principle, 10-fold patient-level cross vali-
Figure 6. Sensitivity (Recall) rate with respect to false positives per
scan. The FROC (average recall rate at the false positives as 0.125,
0.25, 0.5, 1, 2, 4, 8) of 3D Res18 Faster R-CNN is 83.4%, while
the FROC of 3D DPN26 Faster R-CNN is 84.2% with only 14 of
the parameters as 3D Res18 Faster R-CNN. The 3D Res18 Faster
R-CNN has a total recall rate 94.6% for all the detected nodules,
while 3D DPN26 Faster R-CNN has a recall rate 95.8%.
Table 1. Nodule classification comparisons on LIDC-IDRI dataset.
Models Accuracy (%) Year
Multi-scale CNN [26] 86.84 2015
Slice-level 2D CNN [33] 86.70 2016
Nodule-level 2D CNN [33] 87.30 2016
Vanilla 3D CNN [33] 87.40 2016
Multi-crop CNN [27] 87.14 2017
Deep 3D DPN 88.74 2017
Nodule Size+Pixel+GBM 86.12 2017
All feat.+GBM 90.44 2017
dation. There are 1,004 nodules of which 450 are positive.
In the training, we first pad the nodules of size 32×32×32
into 36 × 36 × 36, randomly crop 32 × 32 × 32 from the
padded data, horizontal flip, vertical flip, z-axis flip the data
for augmentation, randomly set 4× 4× 4 patch to zero, and
normalize the data with the mean and standard deviation
obtained from training data. The total number of epochs is
1,050. The initial learning rate is 0.01, and reduce to 0.001
after epoch 525, and finally to 0.0001 after epoch 840. Due
to time and resource limitation for training, we use the fold
1, 2, 3, 4, 5 for test, and the final performance is the average
performance on the five test folds. The nodule classification
performance is concluded in Table 1.
From the table 1, our deep 3D DPN achieves better per-
formance than those of Multi-scale CNN [26], Vanilla 3D
CNN [33] and Multi-crop CNN [27], because of the strong
power of 3D structure and deep dual path network. GBM
with nodule size and raw nodule pixels with crop size as
16 × 16 × 16 achieves comparable performance as multi-
scale CNN [26] because of the superior classification per-
Table 2. Nodule-level diagnosis accuracy (%) between nodule
classification subnetwork in DeepLung and experienced doctors
on doctor’s individually confident nodules.
Dr 1 Dr 2 Dr 3 Dr 4 Average
Doctors 93.44 93.69 91.82 86.03 91.25
DeepLung 93.55 93.30 93.19 90.89 92.74
Table 3. Statistical property of predicted malignant probability for
borderline nodules (%)
Prediction
< 0.1 or
> 0.9
< 0.2 or
> 0.8
< 0.3 or
> 0.7
< 0.4 or
> 0.6
Frequency 64.98 80.14 89.75 94.80
formance of GBM. Finally, we construct feature with deep
3D dual path network features, 3D Faster R-CNN detected
nodule size and raw nodule pixels, and obtain 90.44% ac-
curacy, which shows the effectiveness of deep 3D dual path
network features.
4.4.1 Compared with Experienced Doctors on Their
Individual Confident Nodules
We compare our predictions with those of four “simulated”
experienced doctors on their individually confident nodules
(with individual score not 3). Note that about 1/3 annota-
tions are 3. Comparison results are concluded in Table 2.
From Table 2, these doctors’ confident nodules are easy
to be diagnosed nodules from the performance comparison
between our model’s performances in Table 1 and Table
2. To our surprise, the average performance of our model
is 1.5% better than that of experienced doctors even on
their individually confident diagnosed nodules. In fact, our
model’s performance is better than 3 out of 4 doctors (doc-
tor 1, 3, 4) on the confident nodule diagnosis task. The re-
sult validates deep network surpasses human-level perfor-
mance for image classification [11], and the DeepLung is
better suited for nodule diagnosis than experienced doctors.
We also employ Kappa coefficient, which is a common
approach to evaluate the agreement between two raters, to
test the agreement between DeepLung and the ground truth
[16]. The kappa coefficient of DeepLung is 85.07%, which
is significantly better than the average kappa coefficient of
doctors (81.58%). To evaluate the performance for all nod-
ules including borderline nodules (labeled as 3, uncertain
between malignant and benign), we compute the log likeli-
hood (LL) scores of DeepLung and doctors’ diagnosis. We
randomly sample 100 times from the experienced doctors’
annotations as 100 “simulated” doctors. The mean LL of
doctors is -2.563 with a standard deviation of 0.23. By
contrast, the LL of DeepLung is -1.515, showing that the
performance of DeepLung is 4.48 standard deviation better
than the average performance of doctors, which is highly
statistically significant. It is important to analysis the sta-
Table 4. Comparison between DeepLung’s nodule classification
on all detected nodules and doctors on all nodules.
Method TP Set FP Set Doctors
Acc. (%) 81.42 97.02 74.05-82.67
tistical property of predictions for borderline nodules that
cannot be conclusively classified by doctors. Interestingly,
64.98% of the borderline nodules are classified to be either
malignant (with probability > 0.9) or benign (with proba-
bility < 0.1) in Table 3. DeepLung classified most of the
borderline nodules of malignant probabilities closer to zero
or closer to one, showing its potential as a tool for assisted
diagnosis.
4.5. DeepLung for Fully Automated Lung CT Can-
cer Diagnosis
We also validate the DeepLung for fully automated lung
CT cancer diagnosis on the LIDC-IDRI dataset with the
same protocol as LUNA16’s patient-level split. Firstly, we
employ our 3D Faster R-CNN to detect suspicious nodules.
Then we retrain the model from nodule classification model
on the detected nodules dataset. If the center of detected
nodule is within the ground truth positive nodule, it is a pos-
itive nodule. Otherwise, it is a negative nodule. Through
this mapping from the detected nodule and ground truth
nodule, we can evaluate the performance and compare it
with the performance of experienced doctors. We adopt the
test fold 1, 2, 3, 4, 5 to validate the performance the same
as that for nodule classification.
Different from pure nodule classification, the fully auto-
mated lung CT nodule diagnosis relies on nodule detection.
We evaluate the performance of DeepLung on the detec-
tion true positive (TP) set and detection false positive (FP)
set individually in Table 4. If the detected nodule of center
within one of ground truth nodule regions, it is in the TP
set. If the detected nodule of center out of any ground truth
nodule regions, it is in FP set. From Table 4, the DeepLung
system using detected nodule region obtains 81.42% accu-
racy for all the detected TP nodules. Note that the expe-
rienced doctors obtain 78.36% accuracy for all the nodule
diagnosis on average. The DeepLung system with fully au-
tomated lung CT nodule diagnosis still achieves above av-
erage performance of experienced doctors. On the FP set,
our nodule classification subnetwork in the DeepLung can
reduce 97.02% FP detected nodules, which guarantees that
our fully automated system is effective for the lung CT can-
cer diagnosis.
4.5.1 Compared with Experienced Doctors on Their
Individually Confident CTs
We employ the DeepLung for patient-level diagnosis fur-
ther. If the current CT has one nodule that is classified as
Table 5. Patient-level diagnosis accuracy(%) between DeepLung
and experienced doctors on doctor’s individually confident CTs.
Dr 1 Dr 2 Dr 3 Dr 4 Average
Doctors 83.03 85.65 82.75 77.80 82.31
DeepLung 81.82 80.69 78.86 84.28 81.41
positive, the diagnosis of the CT is positive. If all the nod-
ules are classified as negative for the CT, the diagnosis of
the CT is negative. We evaluate the DeepLung on the doc-
tors’ individually confident CTs for benchmark comparison
in Table 5.
From Table 5, DeepLung achieves 81.41% patient-level
diagnosis accuracy. This is 99% of the average perfor-
mance of four experienced doctors and better than Dr 4 alto-
gether. This performance gives confidence that DeepLung
can be a useful tool to assist doctors’ in their diagon-
sis. We further validate our method against the four doc-
tors’ individual confidential CTs. The Kappa coefficient
of DeepLung is 63.02%, while the average Kappa coeffi-
cient of the doctors is 64.46%. It implies the predictions
of DeepLung are of good agreement with ground truths for
patient-level diagnosis, and are comparable with those of
experienced doctors.
5. Discussion
In this section, we will argue the utility of DeepLung by
visualizing the nodule detection and classification results.
5.1. Nodule Detection
We randomly pick nodules from test fold 1 and visual-
ize them in red circles in the first row of Fig. 7. Detected
nodules are visualized in blue circles of the second row. Be-
cause CT is 3D voxel data, we can only plot the central slice
for visualization. The third row shows the detection prob-
abilities for the detected nodules. The central slice number
is shown below each slice. The diameter of the circle is
relative to the nodule size.
From the central slice visualizations in Fig. 7, we ob-
serve the detected nodule positions including central slice
numbers are consistent with those of ground truth nodules.
The circle sizes are similar between the nodules in the first
row and the second row. The detection probability is also
very high for these nodules in the third row. It shows 3D
Faster R-CNN works well to detect the nodules from test
fold 1.
5.2. Nodule Classification
We also visualize the nodule classification results from
test fold 1 in Fig. 8. We choose nodules that is predicted
right, but annotated incorrectly by some doctors. The first
seven nodules are benign nodules, and the remaining nod-
ules are malignant nodules. The numbers below the fig-
Figure 7. Visualization of central slices for nodule ground truths and detection results. We randomly choose nodules (red circle boxes in
the first row) from test fold 1. Detection results are shown in the blue circles of second row. The center slice numbers are shown below the
images. The last row shows detection probability. The DeepLung performs well for nodule detection.
ures are the DeepLung predicted malignant probabilities
followed by which annotation of doctors is wrong. For the
DeepLung, if the probability is larger than 0.5, it predicts
malignant. Otherwise, it predicts benign. For an experi-
enced doctor, if a nodule is large and has irregular shape, it
has a high probability to be a malignant nodule.
Figure 8. Visualization of central slices for nodule classification
results on test fold 1. We choose nodules that are predicted right
by the DeepLung, but annotated incorrectly by some doctors. The
numbers below the nodules are model predicted malignant proba-
bilities followed by which annotation of doctors is wrong. The first
seven nodules are benign nodules. The rest nodules are malignant
nodules. The DeepLung performs well for nodule classification.
From Fig. 8, we can observe that doctors mis-diagnose
some nodules. The reason may be be that humans are not fit
to process 3D CT data which are of low signal to noise ra-
tio. Perhaps some doctors cannot find some weak irregular
boundaries or erroraneously consider some normal tissues
as nodule boundaries leading to false negatives or false pos-
itives. In addition, doctors’ own internal bias may play a
role in how confident he/she predicts these scans while be-
ing limited to observing only one slice at a time. Machine
learning-based methods can overcome these limitations and
are able to learn complicated rules and high dimensional
features while utilizing all input slices at once without much
problem. From this perspective, DeepLung can potentially
be of great use to doctors in their effort to make consistent
and accurage diagonsis.
6. Conclusion
In this work, we propose a fully automated lung CT can-
cer diagnosis system based on deep learning. DeepLung
consists of two parts, nodule detection and classification.
To fully exploit 3D CT images, we propose two deep 3D
convolutional networks based on 3D dual path networks,
which is more compact and can yield better performance
than residual networks. For nodule detection, we design a
3D Faster R-CNN with 3D dual path blocks and a U-net-
like encoder-decoder structure to detect candidate nodules.
The detected nodules are subsequently fed to nodule clas-
sification network. We use a deep 3D dual path network
to extract classification features. Finally, gradient boost-
ing machine with combined features are trained to classify
candidate nodules into benign or malignant. Extensive ex-
perimental results on public available large-scale datasets,
LUNA16 and LIDC-IDRI datasets, demonstrate the supe-
rior performance of the DeepLung system.
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